Our results highlight the role of SmarcAL1 in regulating lipid catalytic processes and suggest that genetic variations at the SmarcAL1 locus may underlie the observed lipid phenotypes in SIOD patients. The gene discussed is SMARCAL1; the disease is Schimke immuno-osseous dysplasia.